SARS
-
Rheumatoid Arthritis
Enzyme discovery offers new way to regulate cell death process for inflammatory diseases
A WEHI-led study has identified a new enzyme involved in controlling cell death, in findings that could lead to better…
Read More » -
Rheumatoid Arthritis
Study estimates effectiveness of 2-dose and 3-dose mRNA vaccination against Omicron
In a recent study posted to the medRxiv* preprint server, researchers estimated the efficacy of two-dose and three-dose regimens of…
Read More » -
Rheumatoid Arthritis
Chromogranin A plasma levels increase in COVID
A recent paper posted to the Public Library of Science (PLOS) ONE journal showed that plasma levels of chromogranin A (CgA) could…
Read More » -
Rheumatoid Arthritis
Discovering Genetic Variants that Significantly Predispose People to Critical COVID-19
Please can you introduce yourself, tell us about your background in medical informatics, and what inspired your latest research into…
Read More » -
Rheumatoid Arthritis
Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease
In a preprint version of a study posted on medRxiv*, researchers investigated the longevity and intensity of severe acute respiratory…
Read More » -
Rheumatoid Arthritis
Neutralization of BA.1 and BA.2 Omicron variants with monoclonal antibodies
The Omicron variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in November 2021 and rapidly…
Read More » -
Rheumatoid Arthritis
Association between seropositivity and comorbidities after COVID-19 vaccination
In a recent study posted to the medRxiv* preprint server, researchers demonstrated that comorbidities attenuated the chance of seropositivity following coronavirus…
Read More » -
Rheumatoid Arthritis
Study explores prevalence and symptom trajectory of long COVID
A recent study posted to the Research Square* preprint server estimated long-term coronavirus disease 2019 (COVID-19), or, long COVID, and…
Read More » -
Rheumatoid Arthritis
T cell responses in inflammatory bowel disease patients on immune-modifying agents after mRNA COVID-19 vaccination
In a recent study posted to the medRxiv* preprint server, researchers characterized humoral and severe acute respiratory syndrome coronavirus 2…
Read More »